Table 2 Jadad Score of randomized clinical trials included in the meta-analysis
Trial | Study ID | Randomization | Randomization appropriate | Double-blind | Blinding appropriate | Description of withdrawals and dropouts | Total score |
|---|---|---|---|---|---|---|---|
NR | NCT01285609 | 1 | 1 | 1 | 1 | 1 | 5 |
Govindan et al. J Clin Oncol 2017 | |||||||
IMpower130 | NCT02367781 | 1 | 1 | 0 | 0 | 1 | 3 |
West et al. Lancet Oncol 2019 | |||||||
IMpower131 | NCT02367794 | 1 | 1 | 0 | 0 | 1 | 3 |
Jotte et al. J Thorac Oncol 2020 | |||||||
IMpower132 | NCT02657434 | 1 | 1 | 0 | 0 | 1 | 3 |
Nishio et al. J Thorac Oncol 2021 | |||||||
IMpower150 | NCT02366143 | 1 | 1 | 0 | 0 | 1 | 3 |
Socinski et al. J Thorac Oncol 2021 | |||||||
KEYNOTE-189 | NCT02578680 | 1 | 1 | 1 | 1 | 1 | 5 |
Rodríguez-Abreu et al. Ann Oncol 2021 | |||||||
KEYNOTE-407 | NCT02775435 | 1 | 1 | 1 | 1 | 1 | 5 |
Paz-Ares et al. N Engl J Med 2018 | |||||||
TASUKI-52 | NCT03117049 | 1 | 1 | 1 | 1 | 1 | 5 |
Sugawara et al. Ann Oncol 2021 | |||||||
CheckMate 9LA | NCT03215706 | 1 | 1 | 0 | 0 | 1 | 3 |
Paz-Ares et al. Lancet Oncol 2021 | |||||||